title: Kidney cancer: Finding a niche for girentuximab in metastatic renal cell carcinoma.
authors.affiliation: Department of Medical Oncology &Experimental Therapeutics, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, California 91010, USA.
authors.forename: Sumanta K
authors.initials: SK
authors.lastname: Pal
authors.affiliation: Department of Medical Oncology, Huntsman Cancer Hospital, Clinic 2B GU, 1950 Circle of Hope, Salt Lake City, Utah 84112, USA.
authors.forename: Neeraj
authors.initials: N
authors.lastname: Agarwal
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000071231:Carbonic Anhydrase IX / Q000096:biosynthesis; D002292:Carcinoma, Renal Cell / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000378:metabolism; D017322:Clinical Trials, Phase II as Topic / Q000379:methods; D006801:Humans; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000378:metabolism; D008187:Lutetium / Q000008:administration & dosage*; D011868:Radioisotopes / Q000008:administration & dosage*
chemical_list: D000911:Antibodies, Monoclonal; C106533:G250 monoclonal antibody; D011868:Radioisotopes; D008187:Lutetium; C000615061:Lutetium-177; D000071231:Carbonic Anhydrase IX